Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10014416240
Persistent link: https://www.econbiz.de/10013414333
We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...
Persistent link: https://www.econbiz.de/10012965014
Each year, 10,000 individuals die in alcohol-impaired traffic accidents in the United States, while psychoactive drugs are involved in 20% of all fatal traffic accidents. We investigate whether state parity laws for substance use disorder (SUD) treatment have the unintended benefit of reducing...
Persistent link: https://www.econbiz.de/10012957011
We examine the early effects of U.S. state Medicaid expansions under the Affordable Care Act (ACA) on substance use disorder (SUD) treatment utilization. We couple administrative data on admissions to specialty SUD treatment and prescriptions for medications used to treat SUDs in outpatient...
Persistent link: https://www.econbiz.de/10012957014
Opioid overdose deaths in older adults have increased substantially over the past two decades. This increase has occurred despite the availability of effective treatments. Methadone, one of just three medications approved by the Food & Drug Administration for opioid use disorder (OUD) treatment,...
Persistent link: https://www.econbiz.de/10014437015
Persistent link: https://www.econbiz.de/10011956232
Persistent link: https://www.econbiz.de/10011664700
We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...
Persistent link: https://www.econbiz.de/10011596165
We examine the early effects of U.S. state Medicaid expansions under the Affordable Care Act (ACA) on substance use disorder (SUD) treatment utilization. We couple administrative data on admissions to specialty SUD treatment and prescriptions for medications used to treat SUDs in outpatient...
Persistent link: https://www.econbiz.de/10011647627